证券代码：603630 证券简称：拉芳家化 公告编号：2025 - 038 拉芳家化股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ? 首次授予的行权价格：由每股 9.57 元调整为每股 9.48 元 ? 预留授予的行权价格：由每股 8.44 元调整为每股 8.35 元。 拉芳家化股份有限公司（以下简称"公司"）于 2025 年 8 月 27 日召开第五届董事会第 三次会议和第五届监事会第三次会议，会议审议通过了《关于调整第三期股票期权激励计 划行权价格的议案》，根据公司《第三期股票期权激励计划（草案）》 （以下简称"本激励计 划"、"《激励计划（草案）》"）的规定和公司 2023 年年度股东大会授权，公司董事会对第 三期股票期权激励计划的行权价格进行了调整，现将有关事项说明如下： 一、公司已履行的决策程序和信息披露情况 会议，审议通过《关于 <公司第三期股票期权激励计划 草案="草案"> 及其摘要的议案》及其相 关事项的议案，相关事项已经公司董事会薪酬与考核委员会审议通过。公司独立董事王锦 ...

Core Viewpoint - Shanghai Jahwa's mosquito repellent product line, specifically the "Mosquito Repellent Egg 2.0 Series," has an effective repellent duration of 8.2 hours against Aedes albopictus mosquitoes [1] Group 1 - The product line includes four variants: Deep Sea Amber, Rainy Gardenia, Classic Original, and Mountain Pine [1] - The company encourages consumers to purchase these products through official flagship stores and live streaming platforms [1]

Core Viewpoint - The article emphasizes the importance of sun protection products during high-temperature weather, providing guidance on selecting sunscreen clothing, creams, and sprays for effective UV protection [1]. Group 1: Sunscreen Clothing - Suitable for outdoor activities like hiking and cycling [2] - Advantages include physical protection without chemical sunscreen, making it suitable for children, pregnant women, and sensitive skin [1] - Disadvantages include limited coverage, potential for poor breathability leading to skin issues, and the need for careful washing to maintain UPF [1][2] Group 2: Sunscreen Cream - Ideal for facial protection and long-lasting effectiveness [5] - Key selection criteria include SPF and PA values, with SPF 50 blocking 98% of UVB rays and PA+++ or PA++++ recommended for strong UV environments [6][10] - Disadvantages include the need for manual application and potential makeup disruption [5][6] Group 3: Sunscreen Spray - Convenient for use, especially after sports or when wearing makeup [7][10] - Important to follow the "three sprays, three not sprays" rule to minimize risks [11][12][13] - Disadvantages include shorter protection duration and inhalation risks, particularly for children [7][10]

Core Viewpoint - Shanghai Jahwa reported its first loss since going public in 2024, but turned profitable in Q1 2025 with revenue of 1.704 billion yuan and a net profit of approximately 217 million yuan, indicating a recovery and a focus on growth moving forward [2][3]. Financial Performance - In 2024, Shanghai Jahwa achieved revenue of 5.679 billion yuan, a year-on-year decrease of 13.93%, and a net profit of -804 million yuan, a decline of 260.72% [2][3]. - For Q1 2025, the company reported revenue of 1.704 billion yuan, a year-on-year decrease of approximately 10.6%, while net profit was around 217 million yuan [3][4]. Business Strategy and Adjustments - The decline in performance was primarily attributed to goodwill impairment related to the acquisition of the UK baby brand Tommee Tippee, which faced challenges due to low birth rates and increased competition [3]. - The company is undergoing strategic adjustments, including inventory reduction in department stores and transitioning from distributor to self-operated e-commerce channels [4][5]. Online and Offline Business Development - Online business revenue grew by 10.4% year-on-year in Q1 2025, with online sales accounting for a 5.5% increase in proportion [4]. - The company expanded its new retail channels, opening 38,000 new stores in Q1, with sales in emerging channels experiencing double-digit growth [5]. Brand Strategy - Shanghai Jahwa is focusing on core brand development through a "four focus strategy," which includes concentrating on brand building, online presence, and operational efficiency [6]. - Brands are categorized into three tiers: first-tier brands (Liushen and Yuze) are positioned as market leaders, second-tier brands (Baicaojie and Meijiajing) require clearer positioning, and third-tier brands are seen as having potential but need innovative strategies [6][7]. Pricing and Product Strategy - The company has made price adjustments for certain products, such as the Baicaojie Taiji line, to improve conversion rates without affecting gross margins [7]. - Inventory clearance and SKU optimization were implemented to address old stock issues, with plans to further compress SKUs in the new fiscal year [7].

Financial Performance - The company reported a significant decline in basic earnings per share, dropping to -0.2000 yuan in Q1 2025 from -0.0300 yuan in Q1 2024, representing a decrease of 566.67% [1] - Net profit for Q1 2025 was -0.2 billion yuan, compared to -0.03 billion yuan in Q1 2024, indicating a substantial loss [1] - The return on equity (ROE) fell to -2.15% in Q1 2025 from -0.29% in Q1 2024, reflecting a decline of 641.38% [1] - Operating revenue increased to 2.19 billion yuan in Q1 2025, up 7.88% from 2.03 billion yuan in Q1 2024 [1] Shareholder Information - The top ten unrestricted shareholders collectively hold 24.2534 million shares, accounting for 41.21% of the circulating shares, with a decrease of 467,500 shares compared to the previous period [2] - The largest shareholder, Zeng Bensheng, holds 13.9846 million shares, representing 23.76% of the total share capital, with no change in holdings [2] - Shanghai Huiying Investment Partnership holds 3.0721 million shares, which is 5.22% of the total, showing a decrease of 46.75 thousand shares [2] Dividend Policy - The company has announced that it will not distribute dividends or transfer shares this time [3]

Group 1 - The company's stock experienced an abnormal trading fluctuation, with a cumulative closing price increase exceeding 20% over three consecutive trading days from April 1 to April 3, 2025 [1][2][3] - The company conducted a self-examination and confirmed that its operational status is normal, with no significant changes in the market environment, main business, or business model [1][2] - There are no undisclosed major events or information that could significantly impact the stock price, including major asset restructuring, share issuance, or significant business cooperation [2][3] Group 2 - The board of directors confirmed that there are no undisclosed major matters or related plans that should be disclosed according to the Shanghai Stock Exchange regulations [3] - The company urges investors to be cautious and make rational investment decisions in light of the recent stock price volatility [2][3]